Recombinant BRD4 anticorps (AA 149-284)
Aperçu rapide pour Recombinant BRD4 anticorps (AA 149-284) (ABIN6731019)
Antigène
Voir toutes BRD4 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 149-284
-
Marque
- AbFlex®
-
Purification
- Protein A Chromatography
-
Immunogène
- This antibody was raised against a recombinant protein comprising amino acids 149-284 of human BRD4.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Validated Applications:
ChIP-Seq: 4 µg per ChIP
-
Commentaires
-
AbFlex® antibodies are recombinant antibodies (rAbs) that have been generated using defined DNA sequences to produce highly specific, reproducible antibodies. Each AbFlex antibody contains a 6XHis tag, an avidin tag sequence for enzymatic biotin conjugation using the biotin ligase, BirA, and a sortase recognition motif (LPXTG) to attach a variety of labels directly to the antibody including fluorophores, enzymatic substrates (HRP, AP), peptides, drugs as well as solid supports. AbFlex BRD4 antibody was expressed in 293 cells and contains rabbit immunoglobulin heavy and light chains.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified IgG in 140 mM Hepes, pH 7.5, 70 mM NaCl, 32 mM NaOAc, 0.035 % sodium azide, 30 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- BRD4 (Bromodomain Containing 4 (BRD4))
-
Autre désignation
- BRD4
-
Poids moléculaire
- 180 kDa
-
Pathways
- Chromatin Binding, SARS-CoV-2 Protein Interactome
Antigène
-